PICO Portalanswers from OpenAlex & ORCID
Tao Jiang
ResearcherPublications, citations & collaboration network
Tao Jiang is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Tao Jiang have?
PICO Portalindexed works
Tao Jiang has 348 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Tao Jiang have?
PICO Portalcitation count
Tao Jiang has 8,979 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Tao Jiang?
PICO Portalh-index
Tao Jiang has an h-index of 49 in OpenAlex.
What is the i10-index of Tao Jiang?
PICO Portali10-index
Tao Jiang has an i10-index of 124 in OpenAlex.
What is the ORCID of Tao Jiang?
PICO Portalorcid
The ORCID for Tao Jiang is on the source record.
What is the OpenAlex record for Tao Jiang?
PICO Portalopenalex
The OpenAlex for Tao Jiang is on the source record.
What are the most-cited papers on Tao Jiang?
PICO Portalmost cited works
Role of IL-2 in cancer immunotherapy
Tao Jiang, Caicun Zhou, Shengxiang Ren
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
Zhe Yang, Nong Yang, Qiuxiang Ou, Yi Xiang, Tao Jiang, Xue Wu, Hua Bao, Xiaoling Tong, Xiaonan Wang, Yang Shao, Yunpeng Liu, Yan Wang, Caicun Zhou
TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
Guohe Song, Shifeng Xu, Hong Zhang, Yupeng Wang, Chao Xiao, Tao Jiang, Leilei Wu, Tao Zhang, Xing Sun, Lin Zhong, Chongzhi Zhou, Zhao‐Wen Wang, Zhihai Peng, Jian Chen, Xiaoliang Wang
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer
Sha Zhao, Shengxiang Ren, Tao Jiang, Bo Zhu, Xuefei Li, Chao Zhao, Yijun Jia, Jinpeng Shi, Limin Zhang, Xiaozhen Liu, Meng Qiao, Xiaoxia Chen, Chunxia Su, Hui Yu, Caicun Zhou, Jun Zhang, D. Ross Camidge, Fred R. Hirsch
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
Shengxiang Ren, Jianhua Chen, Xingxiang Xu, Tao Jiang, Ying Cheng, Gongyan Chen, Yueyin Pan, Yong Fang, Qiming Wang, Yunchao Huang, Wenxiu Yao, Rui Wang, Xingya Li, Wei Zhang, Yanjun Zhang, Sheng Hu, Renhua Guo, Jianhua Shi, Zhiwu Wang, Peiguo Cao, Donglin Wang, Jian Fang, Hui Luo, Yi Geng, Chunyan Xing, Dongqing Lv, Yiping Zhang, Junyan Yu, Shundong Cang, Zeyu Yang, Wei Shi, Jianjun Zou, Caicun Zhou